These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6642131)

  • 1. [The treatment of thyroid carcinoma. Results of 19 years' use of I-131].
    Gordon F; Juan-Marcos H; Muñoz R
    Gac Med Mex; 1983 Sep; 119(9):356-60. PubMed ID: 6642131
    [No Abstract]   [Full Text] [Related]  

  • 2. 131I dosimetry and thyroid stunning.
    Gerard SK; Park HM
    J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radiotherapy of struma maligna].
    Engelken G; Hymmen U; Schenck P; Wieland C
    Chirurg; 1976 Aug; 47(8):435-8. PubMed ID: 821730
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guidelines and results in the treatment of thyroid cancer].
    Ortíz Berrocal J; Sopena Monforte R; Carril Carril JM; Ramos Sánz J; Martínez R; Chamorro Romero JL
    Rev Clin Esp; 1977 Jun; 145(5):361-8. PubMed ID: 877349
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radioactive iodine in the treatment of thyroid carcinoma].
    Pendić S; Tasić S
    Srp Arh Celok Lek; 1980 Oct; 108(10):1021-9. PubMed ID: 7292160
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results obtained in the treatment of hyperfunctional thyroid adenomas with I-131].
    Holan T; Micluţia M; Derevenco V
    Stud Cercet Endocrinol; 1972; 23(4):271-9. PubMed ID: 4681160
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term results of iodine radioisotope therapy for lung metastasis of thyroid cancer].
    Tsyb AF; Drozdovskiĭ BI; Proshin VV
    Vopr Onkol; 1996; 42(3):73-5. PubMed ID: 8801748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of radioactive iodine in the treatment of toxic adenoma: results of our experience with a group of 17 patients and review of the literature].
    Melián E; Cuellar L; Estopiñán V; Riobó P; Lara JI; Sánchez-Franco F
    Med Clin (Barc); 1988 Mar; 90(9):366-8. PubMed ID: 3292865
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant treatment of thyroid cancer.
    Beauduin M; Hermans J; Majois F
    Acta Otorhinolaryngol Belg; 1987; 41(5):944-5. PubMed ID: 3454107
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
    Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
    Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
    Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
    J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy of carcinoma of the thyroid.
    Howard N; Smithers DW
    Monogr Neoplast Dis Var Sites; 1970; 6():259-68. PubMed ID: 5527677
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant goiter. Retrospective analysis of the patient material and treatment results at the Division of Nuclear Medicine of the 2nd Medical Department of Vienna University from 1973 to 1982].
    Weissel M; Bergmann H; Steidler B; Keminger K; Krisch K; Niederle B; Roka R; Schmalzer E; Willvonseder R; Höfer R
    Acta Med Austriaca; 1983; 10(2-3):83-91. PubMed ID: 6880577
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer].
    Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD
    Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of 30mCi and higher doses of iodine-131 for postoperative thyroid remnant ablation].
    Liu RT; Huang MJ; Huang HS; Huang BY; Lin JD; Wang PW; Tzen KY
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):524-8. PubMed ID: 3625158
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of the plan of therapy on prognosis in thyroid cancer].
    Schümichen C; Schmitt E; Scheuffele C; Blattmann H; Pauli-Harnasch C
    Nuklearmedizin; 1983 Apr; 22(2):97-105. PubMed ID: 6866782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The place of ionizing radiation in the treatment of thyroid carcinoma.
    Millburn L; Ameen D
    Otolaryngol Clin North Am; 1980 Feb; 13(1):109-13. PubMed ID: 7366995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 20. Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer.
    Robbins RJ; Pentlow KS
    J Nucl Med; 2003 Jul; 44(7):1069-71. PubMed ID: 12843222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.